Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...

書目詳細資料
主要作者:	Hobbs, F
格式:	Journal article
語言:	English
出版:	2003

相似書籍

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
由: article Editorial
出版: (2020-09-01)

Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
由: Hobbs, R, et al.
出版: (2005)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
由: Alberto J Lorenzatti, et al.
出版: (2020-02-01)

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
由: Mach, F, et al.
出版: (2019)

Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
由: Meor Anuar Shuhaili, Meor Fairuz Rizal, et al.
出版: (2018)

Seasonal variation lipid levels in the patients with dyslipidaemia
由: I V Radysh, et al.
出版: (2009-12-01)

Cardiovascular risk management in primary care.
由: Hobbs, F
出版: (2002)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
由: Francois Mach, et al.
出版: (2020-06-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
由: Sung-Bum Lee, et al.
出版: (2022-07-01)

Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: a malaysian perspective
由: Wan Ahmad, Wan Azman, et al.
出版: (2023)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
由: M R Essop, et al.
出版: (2023-11-01)

Managing dyslipidaemia in patients with chronic kidney disease
由: Ashwani Mehta
出版: (2024-03-01)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
由: Alicja E. Grzegorzewska, et al.
出版: (2021-03-01)

Serum zinc levels in diabetic patients with and without dyslipidaemia and cardiovascular diseases
由: Lakmal Jayaweera, et al.
出版: (2020-08-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
由: Saxena S, et al.
出版: (2015-07-01)

New concepts in the management of dyslipidaemia
由: Baris Gencer, et al.
出版: (2016-11-01)

Managing dyslipidaemia in young adults
由: Jamshed J. Dalal, et al.
出版: (2024-03-01)

Role of statins in the management of dyslipidaemia
由: Saumitra Ray
出版: (2024-03-01)

The changing paradigm of dyslipidaemia management
由: Ruvan Ekanayaka
出版: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
由: Iciar Martín-Timón, et al.
出版: (2018-11-01)

The scale of heart failure: diagnosis and management issues for primary care.
由: Hobbs, F
出版: (1999)

Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
由: Hobbs, F
出版: (2004)

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
由: Maciej Banach, et al.
出版: (2022-09-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
由: Alberto Zambon
出版: (2020-04-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
由: Di Liu, et al.
出版: (2018-08-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
由: Anandita Agarwala, et al.
出版: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
由: Giuseppe Danilo Norata
出版: (2012-01-01)

Secondary dyslipidaemia
由: D.J. Blom
出版: (2011-07-01)

Diabetic dyslipidaemia
由: Subashini C. Thambiah, et al.
出版: (2021-08-01)

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
由: Martina Meszaros, et al.
出版: (2022-10-01)

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
由: Erhardt, L, et al.
出版: (2008)

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study
由: In Wong, et al.
出版: (2020-01-01)

Optimisation of lipids for prevention of cardiovascular disease in a primary care
由: Smita Bakhai, et al.
出版: (2018-07-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
由: Tiny Nair
出版: (2024-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
由: Alberico L. Catapano, et al.
出版: (2017-06-01)

Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
由: Dalia Luksiene, et al.
出版: (2014-01-01)

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women
由: Balamurugan Vaideki, et al.
出版: (2023-01-01)

Dyslipidaemia in endocrine disorders
由: Kalyani Sridharan, et al.
出版: (2024-03-01)

Treatment of Dyslipidaemia in Children
由: Riccardo Fiorentino, et al.
出版: (2021-08-01)

Dyslipidaemia in Sri Lanka
由: Anne Thushara Matthias, et al.
出版: (2022-01-01)